NIP July 2018- frequently asked questions

To assist healthcare providers and families with the transition to the new NIP schedule on July 1 2018, MVEC has created a reference page outlining frequently asked questions (FAQ's) adapted from our recent Clinical Vaccinology Update- A Special Edition.

For further information please refer to our following MVEC page:

NIP schedule changes July 1 2018-FAQs


National Immunisation Program (NIP) schedule changes - 1 July 2018

From 1 July 2018, there will be significant changes to the National Immunisation Program (NIP) schedule and we are keen to ensure you have access to the information you need to implement the new schedule.

Changes to the childhood immunisation schedule aim to improve protection against meningococcal, pneumococcal and Haemophilus influenzae type b diseases.

In addition, maternal pertussis (dTpa) vaccination for pregnant women has been listed on the NIP to guarantee its ongoing access and availability.

From 1 July 2018, the NIP childhood schedule will be updated so that:

  • at 12 months of age, children will receive a meningococcal ACWY vaccine (replacing meningococcal C vaccination);
  • at 18 months of age, children will receive the booster Hib vaccine dose, protecting against 嗜血杆菌 流感杆菌 type B (previously given as a combined vaccine with meningococcal C at 12 months); and
  • at 2, 4 and 12 months of age, children will receive a pneumococcal vaccine (instead of at 2, 4 and 6 months).

Note that at risk children and Aboriginal and Torres Strait Islander children living in Queensland, the Northern Territory, South Australia and Western Australia will continue to receive 4 doses, at 2, 4, 6 and 12 months of age.

Educational and promotional communication resources for vaccination providers and consumers to support awareness of the schedule changes are now available.

Hardcopy materials, accompanied by correspondence from the Chief Medical Officer, have been mailed to vaccination providers around the country. The resources are also available for download or order online through the Department of Health website health.gov.au/immunisation.

To assist we encourage you to:

  • learn about the new schedule so that you are able to explain the changes and administer the new schedule correctly.
  • promote the new schedule by displaying the program posters and materials in clinics.
  • administer the dTpa vaccine to pregnant women. You can administer the vaccine to pregnant women early in the third trimester as soon as it is available to you.
  • continue to promote free influenza vaccines to pregnant women. Promotional materials for influenza vaccination are also available through the Department of Health’s website gov.au/immunisation.
  • report vaccinations to the Australian Immunisation Register (AIR). Make sure you report all vaccinations to the AIR. Adult vaccines can be recorded along with child vaccines in the AIR.

 


ASID Annual Scientific Meeting 2018

The Annual Scientific Meeting for The Australasian Society for Infectious Diseases (ASID) was recently held on the Gold Coast in May 2018. AEFI-CAN & AusVaxSafety ran an Adult Immunisation Satellite Workshop entitled ‘Vaccination Is Not Just For Kids’: What Infectious Disease Physicians Need To Know. Fantastic presentations from this workshop are now available:

For further information on influenza please view our 流感疫苗建议 页。


Presentations available online

Thankyou to all those who attended our Clinical Vaccinology Update 2018- A Special Edition. The presentations are now available online via the Event 页。


2018年6个月至5岁以下儿童免费流感疫苗

2018 年,维多利亚州将免费为以下人群提供流感疫苗: 全部 6个月至5岁以下的儿童。如需了解更多信息以及如何获取疫苗,请前往我们的 MVEC Free Influenza vaccine for children in 2018 参考页


Thinking about getting your child the Influenza vaccine?

With the roll out of the 2018 Influenza vaccine the following article may help provide some clarification regarding immunising children

The Conversation: thinking about getting your child the flu vaccine?

For further information regarding the Influenza vaccine please refer to our page MVEC:流感疫苗建议


Menveo® (Meningococcal A, C, W, Y) vaccine shortage

GSK has announced that there is a current shortage in the supply of Menveo® vaccine for the remainder of 2018. Refer to the TGA announcement for further information. For alternate Meningococcal immunisation options please see our MVEC:脑膜炎球菌病和疫苗


Influenza 2018

MVEC has now updated it's Influenza recommendations for the 2018 season. Please follow the link for further information MVEC:流感疫苗建议


Changes to the No Jab, No Play legislation

As of February 28 2018, changes to the "No Jab, No Play" legislation have come into effect. Only Immunisation History statements provided by the Australian Immunisation Register (AIR) will be the accepted proof of immunisation. Previous forms of documentation (eg GP letter or local council statement) will not be accepted. For further information refer to MVEC's No Jab No Play reference page.


流感疫苗和鸡蛋过敏更新

根据澳大利亚临床免疫学和过敏症学会的最新指南,可以在社区疫苗接种诊所(可能有也可能没有直接的医生监督)安全地为有和没有鸡蛋过敏(包括鸡蛋过敏反应)的人接种流感疫苗。这是单剂量,然后是推荐的 15 分钟观察期。请参考我们的 MVEC:过敏和免疫 页面了解更多详情。